Report overview
The global Predictive and Presymptomatic Testing market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.�
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Presymptomatic Testing segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome, Myriad Genetics, Inc., Pathway Genomics Corporation, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Predictive and Presymptomatic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Predictive and Presymptomatic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive and Presymptomatic Testing. This report contains market size and forecasts of Predictive and Presymptomatic Testing in global, including the following market information:
Global Predictive and Presymptomatic Testing market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Predictive and Presymptomatic Testing companies in 2024 (%)
Total Market by Segment:
Global Predictive and Presymptomatic Testing market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Predictive and Presymptomatic Testing market segment percentages, by Type, 2024 (%)
Presymptomatic Testing
Predispositional Testing
Global Predictive and Presymptomatic Testing market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Predictive and Presymptomatic Testing market segment percentages, by Application, 2024 (%)
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
Global Predictive and Presymptomatic Testing market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Predictive and Presymptomatic Testing market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Predictive and Presymptomatic Testing revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Predictive and Presymptomatic Testing revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Predictive and Presymptomatic Testing, market overview.
Chapter 2: Global Predictive and Presymptomatic Testing market size in revenue.
Chapter 3: Detailed analysis of Predictive and Presymptomatic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Predictive and Presymptomatic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
